 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/21/2017 |
$4.90 |
$5.15 |
$4.85 |
$5.00 |
259.70K | | 06/22/2017 |
$5.30 |
$6.05 |
$5.25 |
$5.60 |
1.27M | | 06/23/2017 |
$5.65 |
$6.05 |
$5.35 |
$6.00 |
2.85M | | 06/26/2017 |
$5.95 |
$6.05 |
$5.70 |
$5.95 |
495.30K | | 06/27/2017 |
$6.00 |
$6.40 |
$5.80 |
$6.20 |
401.10K |
|
|
| Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening diseases. Co.'s primary programs are ABO-101 and ABO-102, adeno-associated virus-based gene therapies for Sanfilippo syndrome. Co. is also developing ABO-201 gene therapy for Juvenile Neuronal Ceroid Lipofuscinoses also known as juvenile Batten disease; and ABO-301 for Fanconi anemia disorder using a CRISPR/Cas9-based gene editing approach to gene therapy program for blood diseases. In addition, Co. is also developing plasma protein therapies including PTB-101 SDF Alpha™ (alpha-1 protease inhibitor) for inherited chronic obstructive pulmonary disease. |
|
|
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on June 21, 2017, ABEO opened at $4.90, traded as high as $5.15 and as low as $4.85, and closed at $5.00. Trading volume was a total of 259.70K shares. On June 22, 2017, ABEO opened at $5.30, traded as high as $6.05 and as low as $5.25, and closed at $5.60. Trading volume was a total of 1.27M shares. On June 23, 2017, ABEO opened at $5.65, traded as high as $6.05 and as low as $5.35, and closed at $6.00. Trading volume was a total of 2.85M shares. On June 26, 2017, ABEO opened at $5.95, traded as high as $6.05 and as low as $5.70, and closed at $5.95. Trading volume was a total of 495.30K shares. On June 27, 2017, ABEO opened at $6.00, traded as high as $6.40 and as low as $5.80, and closed at $6.20. Trading volume was a total of 401.10K shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/28/2007 |
|
| End date: |
06/27/2017 |
|
| Start price/share: |
$5.05 |
|
| End price/share: |
$6.20 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
22.77% |
|
| Average Annual Total Return: |
2.07% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$12,275.24 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 06/21/2017 | $5.00 | | 06/22/2017 | $5.60 | | 06/23/2017 | $6.00 | | 06/26/2017 | $5.95 | | 06/27/2017 | $6.20 |
|
|
